Taking together, we can conclude that the combination between MLPA Sanger sequencing and, possibly, TGS methods for FANCA mutations screening seems to be the appropriate molecular approach for a precise diagnosis of FA patients in NA (Figure 6). This evidence concerns the gene FANCA and Friedreich ataxia.